Surfaces of Nanoparticles and Porous Materials, Journal of Nanoparticle Research. [37], In 2018, it started litigation against NHS England in the Technology and Construction Court claiming that they breached procurement rules and had not treated the company fairly during what was described as "the single largest medicines procurement ever done by the NHS" when seeking suppliers for hepatitis C treatments. Richard's mailing address filed with the SEC is North Waukegan Road, Waukegan, North Chicago, Lake County, Illinois, 60088, United States. [37] AbbVie estimates global sales of the drug at $1 billion in 2016 and $5 billion in 2020. Some analysts are calling for copper to rise another 50-100%! Key Contributions to the Board: As a result of his service as Abbott's executive vice president, Pharmaceutical Products Group, his previous service as Abbott's president and chief operating officer and his more than 30-year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. [27][28] In October, AbbVie announced they would acquire U.K.-based biotechnology business DJS Antibodies for $225 milion, in a deal that gives it access to an experimental drug for an aggressive lung disease as well as technology to develop certain kinds of antibody medicines. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. Prior to AbbVies separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. Selective Hydrogenation of Acetylene through a Short Contact Time Reactor. 6823 St. Charles Avenue Originally an executive vice president The most recent insider tranaction occured on December, 12th when EVP Timothy J Richmond sold 42,370 shares worth more than $6,924,952.80. WebRichard Gonzalez is 70 years old and was born on 05/24/1952. The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list): Mavyret/Maviret (glecaprevir/pibrentasvir), "AbbVie Inc. 2021 Annual Report (Form 10-K)", "Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company", "Abbott Completes Separation of Research-Based Pharmaceuticals Business", "More than splitting pills: Health care giant Abbott Laboratories ready to spin off AbbVie", "Drug companies should drop their patents and collaborate to fight coronavirus", "Senate Finance Committee launches investigation into Abbvie tax practices", "AbbVie Faces U.S. Senate Pressure Over Tax Payments", "Google-Backed Calico Joins AbbVie in Up to $1.5B Collaboration", "After Tax Inversion Rules Change, AbbVie and Shire Agree to Terminate Their Deal", "AbVie Acquires Oncology Drug Firm Pharmacyclics for $21B", "AbbVie to Buy Pharmacyclics in $21 Billion Deal", "AbbVie (ABBV) Announces Completion of Pharmacyclics Acquisition", "Abbvie Terminates Development Deal with Halozyme - GEN", "AbbVie to Acquire Stemcentrx for Up to $9.8B", "Galapagos, AbbVie Expand CF Collaboration to Up-to-$600M", "Botox maker Allergan bought by US drug giant for $63bn", "AbbVie Strikes $63 Billion Deal for Botox Maker Allergan", "FTC Approves Final Order Imposing Conditions on AbbVie Inc.'s Acquisition of Allergan plc", "AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go", "AbbVie Dives into STING and Boehringer Ingelheim Snaps Up Swiss-based AMAL", "AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma", "Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio", "With Myeloma Drug Proving Merit in Phase I, AbbVie Scoops up TeneoOne", "AbbVie Bolsters Neuro Platform with $1B Syndesi Buy", "AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio", "AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy", "AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes", "AbbVie, Maker of World's No. In May, Scott Thompson left as CEO of Yahoo Inc. after a shareholder in the Sunnyvale, Calif.-based Internet company revealed that Mr. Thompson's bachelor's degree from Stonehill College in Easton, Mass., was in business, not computer science, as described in a company biography and regulatory filings. We know that Richard A. Gonzalez had been residing in Mr. Gonzalez's status at the University of Miami could not immediately be confirmed. According to his family tree, he married Tina M. (Hernandez) Gonzalez on September 18, 1999 in Texas and they later separated on July 17, 2002 in Texas. Prabook is a registered trademark of World Biographical Encyclopedia, Inc. Richard A. Gonzalez, pharmaceutical executive. WebBiography Mini Bio (1) Richard A. Gonzalez is known for The Naked Gun 2: The Smell of Fear (1991). Mr. Gonzalez is the chairman and chief executive officer of AbbVie. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. [47][48], In July 2022 the company agreed to pay up to $2.37 billion to settle U.S. lawsuits against its Allergan unit over the marketing of opioid painkillers. Stud. [35] However, the first non-blinded, randomized trial found the drug not useful to treat severe COVID-19. Aspects 300, 3-10 (2007). Radio Shack Corp., Dave Edmondson, 2006: Mr. Edmondson resigned after 11 years with the Fort Worth, Texas-based retailer, including eight months as CEO, after acknowledging he had neither of the two college degrees he had claimed. [8] In a letter to AbbVie CEO Richard Gonzalez, Wyden noted the company suffered a 2020 pretax loss in the US of $4.5 billion and an overseas pretax profit of $7.9 billion the same year. Richard Gonzalez is 65, he's been the Chairman of the Board and Chief Executive Officer of Abbvie Inc since 2013. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. "[3] The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. Richard Gonzalez biography. The most active insiders traders include Richard A Gonzalez, Frederick H Waddell, and Glenn F Tilton. Catalysis Letters, 86, Vol. As part of the settlement, AbbVie, denied any wrongdoing. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. Prior to AbbVies separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. Mr. Gonzalez owns over 174,100 units of Abbvie Inc stock worth over $84,967,040 and over the last 20 years he sold ABBV stock worth over $87,642,548. Journal of Biomedical Materials Research: Part A, Vol 78, Issue 3, 446-448 (2006). On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. Synthesis and Applications of Catalysts Prepared by the Sol-gel Method in Emerging Fields in Sol-Gel Science and Technology. They sold a total of 612,950 shares worth more than $93,689,817.55. We may be at the beginning of a copper bull run the likes we've never seen before. The new Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer. Over the last 10 years, insiders at Abbvie Inc have traded over $201,429,813 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 AbbVie Ireland. Biocompatible Titania Microtubes Formed by Nanoparticles and its Application in the Drug Delivery of Valprroic Acid. Richard L Gonzalez was born on August 16, 1967. The most active insiders traders include Richard A Gonzalez, Frederick H Waddell, eGlenn F Tilton. Actas do XVII Congreico de Catalysis, Porto, Portugal, 803-804, (2000). He also served as President and Chief Operating Officer, prior to a brief retirement. Over the last 10 years, insiders at Abbvie Inc have traded over $201,429,813 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 [49], AbbVie reported Total CO2e emissions (Direct + Indirect) for the twelve months ending 31 December 2020 at 508 Kt (-57 /-10.1% y-o-y). Optimization of the Surface Concentration of Sulfur in the Isomerization of n-Butane over Sulfated Zirconia Catalysts. To power the green revolution, copper demand continues to skyrocket with no end in sight. The company whose name means "truth" in Latin was acquired by Mountain View, Calif.-based Symantec Corp. in 2005. Get the best business coverage in Chicago, from breaking news to razor-sharp analysis, in print and online. [11], On March 4, 2015, AbbVie announced its agreement to acquire the oncology firm Pharmacyclics and its treatment for blood cancers, ibrutinib; AstraZeneca had also been bidding to acquire Pharmacyclics. The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. [50] and plans to reduce emissions 25% by 2025 from a 2015 base year.[51]. Learn More on Richard A. Gonzalez's salary. 2 position. He also worships all the Gods and goddesses and also celebrates all the festivals. Insiders at AbbVie own 0.1% of the company. Ms. Brotz declined to say exactly when Abbott learned about the errors, except to say it was some time ago. The company corrected the information on its website immediately after the errors were discovered, she said. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. The oldest executive at Abbvie Inc is EdwardLiddy, 73, who is the Independent Director. [25] In June, Abbvie announced it would acquire TeneoOne and its lead compound TNB-383B. Abbvie Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. R.Marcus. These studies are carried out jointly between Tulane University, the Institute of Neurology and Neurosurgery in Mexico City and the National Metropolitan University of Mexico. 19(3-4) 203-335 (2002). B.Ch.E., Rensselaer Polytechnic Institute, 1961 M.A., The Johns Hopkins University, 1963 Ph.D., The Johns Hopkins University, 1965. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. Business They can also be used as a follow up to the surgical removal of malignant tumors. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. Mr. Gonzalez earned a salary of $1,700,000.00, stock awards of $12,573,689.00, options awards of $3,134,649.00, non-equity compensation of $4,908,750.00, and other compensation of $814,073.00. There are no executives at Abbvie Inc getting paid more. In addition, he makes $21,610,600 as Chairman of the Board e Chief Executive Officer at Abbvie Inc. Richard has made over 34 trades of the Abbvie Inc stock since 2003, according to the Form 4 filled with the SEC. Richard's ethnicity is Hispanic American, whose political affiliation is currently a registered Democrat; and religious views are listed as Tailoring the Photocatalytic Reaction Rate of a nanostructured TiO2 matrix using Additional Gas Phase Oxygen. [44][45], In 2018, AbbVie agreed to pay $25 million to resolve allegations that it made use of kickback schemes to promote its cholesterol drug Tricor. The corporate mailing address for Mr. Gonzalez and other AbbVie executives is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. Mr. Gonzalez owns over 174,100 units of Abbvie Inc stock worth over $82,136,458 and over the last 20 years he sold ABBV stock worth over $87,642,548. 12-24. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. [14] The Pharmacyclics name was retained, and it operates as a subsidiary of AbbVie from its previous Sunnyvale, California, headquarters. A Molecular Vibrational Analysis and MAS-NMR Spectroscopy Study of Epilepsy Drugs Encapsulated in TiO2-Sol-Gel Reservoirs. Lopez, T., Alvarez, M, Gonzalez, R.D., Uddin.M.J., Bustos,J., Arroyo, S., and Sanchez, A. Adsorption 17, 573-581 (2011), Nano-structured Pt(NH3)4CI2/Si02 for nanomedicine. He died on June 11, 2004 at 36 years of age. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. In-situ Release of Antiepileptic Drugs from Nanostructured Reservoirs. [7], In June 2021, the US Senate Finance Committee, under Chair Ron Wyden (D-OR), began an investigation to determine if the company used the Tax Cuts and Jobs Act of 2017 to buy back its own stock using income saved by the tax law.
Police Simulator: Patrol Officers Shooting, Numbers 1 500 Copy And Paste, Timeline Of Rizal's Childhood And Early Education, Articles R